Effects of pioglitazone and glimepiride on glycemic control and insulin sensitivity in Mexican patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, parallel-group trial

Clinical Therapeutics
Meng TanGLAD Study Group

Abstract

Pioglitazone and glimepiride improve glycemic control in patients with type 2 diabetes mellitus by different mechanisms. Pioglitazone is a thiazolidinedione that reduces insulin resistance, and glimepiride is a sulfonylurea insulin secretagogue. The goals of this study were to compare changes in measures of glycemic control and insulin sensitivity in Mexican patients with type 2 diabetes who received pioglitazone or glimepiride for 1 year. This was a multicenter, 52-week, double-blind, parallel-group trial. Patients were randomized to receive monotherapy with either glimepiride (2 mg QD initially) or pioglitazone (15 mg QD initially). Doses were titrated (maximal doses: pioglitazone 45 mg, glimepiride 8 mg) to achieve glycemic targets (fasting blood glucose < or =7 mmol/L and 1-hour postprandial blood glucose < or =10 mmol/L). Insulin sensitivity (primary end point) was evaluated in terms of the Homeostasis Model Assessment for Insulin Sensitivity (HOMA-S), the Quantitative Insulin Sensitivity Check Index (QUICKI), and fasting serum insulin (FSI) concentrations. Glycemic control was evaluated in terms of glycosylated hemoglobin (HbA(1c)) values and fasting plasma glucose (FPG) concentrations. Patients were encouraged to maintai...Continue Reading

References

Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
Sep 1, 1996·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·K E DraegerR Rosskamp
Sep 1, 1996·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·D G Dills, J Schneider
Sep 1, 1996·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·K GeisenJ G Papp
Feb 28, 2001·Diabetes, Obesity & Metabolism·L C Groop
Mar 7, 2001·Diabetes, Obesity & Metabolism·M R BurgeD S Schade
Aug 9, 2001·Coronary Artery Disease·S RosenblattUNKNOWN Pioglitazone 026 Study Group
Jun 7, 2002·The Journal of Clinical Endocrinology and Metabolism·Yoshinori MiyazakiRalph A DeFronzo
Jul 3, 2002·Drugs·Fabrice M A C MartensTon J Rabelink
Aug 7, 2002·Pharmacology & Therapeutics·Helen VosperColin N A Palmer
Oct 9, 2002·Current Medical Research and Opinion·Stanley H Hsia, Mayer B Davidson

❮ Previous
Next ❯

Citations

Jun 7, 2013·Diabetologia·Zubin PunthakeeHertzel C Gerstein
May 18, 2010·Diabetes Technology & Therapeutics·Giuseppe Derosa, Pamela Maffioli
May 29, 2008·Diabetes, Obesity & Metabolism·E MannucciN Marchionni
Jun 28, 2007·International Journal of Clinical Practice. Supplement·G Derosa
Jan 1, 2009·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Giuseppe Derosa, Sibilla At Salvadeo
Apr 22, 2010·Vascular Health and Risk Management·Toshikazu Yamanouchi
Jan 12, 2012·Journal of Endocrinological Investigation·A AvogaroG Crepaldi
Oct 24, 2006·Diabetes Research and Clinical Practice·Helen D BerlieLinda A Jaber
Dec 24, 2010·Journal of Evaluation in Clinical Practice·Veronika VlckovaSaad Shakir
Apr 19, 2013·Diabetes, Obesity & Metabolism·M MonamiE Mannucci
May 28, 2009·Fundamental & Clinical Pharmacology·Jochen Seufert
Jul 20, 2005·Diabetic Medicine : a Journal of the British Diabetic Association·T YamanouchiT Kawasaki
Aug 18, 2006·Current Medical Research and Opinion·Bart Staels
Jun 10, 2011·Expert Opinion on Pharmacotherapy·Nikolaos PapanasEfstratios Maltezos
Jun 21, 2005·Journal of the American College of Cardiology·Andreas PfütznerThomas Forst
May 16, 2006·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·George B KudoloJanet Blodgett
Jul 30, 2015·The Cochrane Database of Systematic Reviews·Bianca HemmingsenThomas P Almdal
Apr 3, 2012·The Journal of Clinical Endocrinology and Metabolism·Maria FleseriuUNKNOWN SEISMIC Study Investigators
Oct 21, 2006·The Cochrane Database of Systematic Reviews·B RichterS H Ebrahim
May 8, 2009·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Veronika VlckovaSaad A W Shakir
May 14, 2010·Postgraduate Medicine·Annie A MavianRobert R Henry
May 1, 2007·Expert Review of Endocrinology & Metabolism·Thomas Forst, Andreas Pfützner
Apr 20, 2021·Diabetes & Metabolism Journal·Jaehyun BaeBong-Soo Cha

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.